Tactile Systems Technology, Inc. (NASDAQ:TCMD – Get Rating) has been given a consensus rating of “Hold” by the six ratings firms that are currently covering the stock, MarketBeat reports. Two research analysts have rated the stock with a hold rating and one has given a buy rating to the company. The average twelve-month price objective among analysts that have updated their coverage on the stock in the last year is $34.00.
A number of research firms recently weighed in on TCMD. Piper Sandler decreased their price target on Tactile Systems Technology from $40.00 to $28.00 in a research report on Wednesday, February 23rd. Zacks Investment Research upgraded Tactile Systems Technology from a “strong sell” rating to a “hold” rating in a research report on Tuesday, January 11th. TheStreet lowered Tactile Systems Technology from a “c-” rating to a “d” rating in a research report on Wednesday, February 23rd. StockNews.com initiated coverage on Tactile Systems Technology in a report on Thursday, March 31st. They set a “hold” rating for the company. Finally, BTIG Research reduced their price target on Tactile Systems Technology from $44.00 to $29.00 in a report on Wednesday, February 23rd.
A number of institutional investors have recently bought and sold shares of the business. Advisor Group Holdings Inc. boosted its stake in Tactile Systems Technology by 20.3% in the third quarter. Advisor Group Holdings Inc. now owns 2,546 shares of the company’s stock worth $113,000 after purchasing an additional 429 shares in the last quarter. Voya Investment Management LLC boosted its position in Tactile Systems Technology by 2.2% during the third quarter. Voya Investment Management LLC now owns 21,173 shares of the company’s stock valued at $941,000 after purchasing an additional 465 shares during the last quarter. Marshall Wace North America L.P. acquired a new position in Tactile Systems Technology during the first quarter valued at approximately $25,000. California State Teachers Retirement System boosted its position in Tactile Systems Technology by 3.1% during the fourth quarter. California State Teachers Retirement System now owns 27,210 shares of the company’s stock valued at $518,000 after purchasing an additional 809 shares during the last quarter. Finally, IndexIQ Advisors LLC boosted its position in Tactile Systems Technology by 11.1% during the third quarter. IndexIQ Advisors LLC now owns 8,251 shares of the company’s stock valued at $367,000 after purchasing an additional 826 shares during the last quarter. 98.59% of the stock is currently owned by institutional investors.
NASDAQ:TCMD opened at $18.03 on Monday. The company has a debt-to-equity ratio of 0.40, a current ratio of 3.29 and a quick ratio of 2.74. Tactile Systems Technology has a 1-year low of $13.37 and a 1-year high of $61.13. The firm has a market cap of $359.27 million, a price-to-earnings ratio of -30.05 and a beta of 1.37. The company has a fifty day moving average of $18.58.
Tactile Systems Technology (NASDAQ:TCMD – Get Rating) last released its quarterly earnings results on Tuesday, February 22nd. The company reported ($0.28) earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.06 by ($0.34). Tactile Systems Technology had a negative net margin of 5.68% and a negative return on equity of 7.31%. The company had revenue of $61.73 million during the quarter, compared to analyst estimates of $58.22 million. During the same quarter last year, the business earned $0.61 EPS. On average, analysts anticipate that Tactile Systems Technology will post -0.41 EPS for the current year.
Tactile Systems Technology Company Profile (Get Rating)
Tactile Systems Technology, Inc, a medical technology company, engages in the development and provision of medical devices for chronic diseases in the United States. The company offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema; Entre system, a portable pneumatic compression device that is used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers; and AffloVest, a portable high frequency chest wall oscillation test for the treatment of retained pulmonary secretions such as bronchiectasis, cystic fibrosis, and various neuromuscular disorders.
Featured Stories
Receive News & Ratings for Tactile Systems Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tactile Systems Technology and related companies with MarketBeat.com's FREE daily email newsletter.
Gloss